Article
Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib.
Pathology oncology research : POR - 1 Jan 2003
de Silva Chandu M V, Reid Robin
Abstract excerpt
Gastrointestinal stromal tumors (GISTs) have been recognised as a biologically distinctive tumor type, different from smooth muscle and neural tumors of the gastrointestinal tract. They constitute the majority of gastrointestinal mesenchymal tumors. They are defined and diagnosed by the expression of a protooncogene protein called CD117 detected by immunohistochemistry. It is now believed that GISTs originate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
